Challenges in treating radioiodine-refractory thyroid cancer: a global perspective with a focus on developing nations in Latin America.
Gustavo Cancela E PennaK M A B RajãoKamilla Maria Araújo Brandão RajãoP H CostaP H CarvalhoG A GomesG A AvelarAline Lauda Freitas ChavesFabián PitoiaPublished in: Endocrine (2024)
Beyond the recognized need for prospective randomized clinical trials to determine the optimal first-line drug and the timing of molecular testing, this type of manuscript plays a pivotal role in stimulating discussions and disseminating comprehensive knowledge about the challenges associated with treating and monitoring patients with radioiodine-refractory thyroid carcinoma, especially in developing countries.